Condello Francesco, Cacia Michele, Sturla Matteo, Terzi Riccardo, Sánz-Sanchez Jorge, Reimers Bernhard, Gasparini Gabriele L, Pagnotta Paolo, Sorrentino Sabato, Spaccarotella Carmen, Indolfi Ciro, Polimeni Alberto
Department of Biomedical Sciences, Humanitas University, 20090 Milan, Italy.
IRCCS Humanitas Research Hospital, 20089 Milan, Italy.
J Clin Med. 2022 Nov 27;11(23):7013. doi: 10.3390/jcm11237013.
Background: Simultaneous ulnar and radial artery compression (SURC) has emerged as a strategy to increase radial artery flow and mitigate radial artery occlusion (RAO) while achieving adequate hemostasis after transradial access (TRA), though its technical adoption has been limited worldwide. Methods: A systematic search of studies comparing SURC versus isolated radial artery compression after TRA for coronary angiography and/or intervention was performed. Data were pooled by meta-analysis using random-effects models. Odds ratios (OR) with relative 95% confidence intervals (CI) and standardized mean difference were used as measures of effect estimates. The primary endpoint was the occurrence of overall RAO. Results: A total of 6 studies and 6793 patients were included. SURC method as compared to isolated radial artery compression was associated with a lower risk of RAO both overall (OR 0.29; 95% CI, 0.13−0.61, p < 0.001; number needed to treat to benefit [NNTB] =38) and in-hospital (OR 0.28; 95% CI: 0.10 to 0.75; p = 0.01, NNTB = 36), with a reduced risk of unsuccessful patent hemostasis (OR: 0.13; 95% CI: 0.02 to 0.85; p = 0.03, NNT = 5) and upper extremity pain (OR: 0.48; 95% CI: 0.24 to 0.95; p = 0.04, NNTB = 124). No significant difference was observed in hemostasis time and in the risk of hematoma. Conclusion: Compared to isolated radial artery compression, SURC is associated with lower risk of RAO, unsuccessful patent hemostasis, and reported upper limb pain, without any trade-off in safety outcomes. With further development of dedicated dual compression devices, the proposed technique should be freed from usage constraints.
尺桡动脉同时压迫(SURC)已成为一种增加桡动脉血流并减轻桡动脉闭塞(RAO)的策略,同时在经桡动脉通路(TRA)后实现充分止血,尽管其技术应用在全球范围内受到限制。方法:对比较TRA后SURC与单纯桡动脉压迫用于冠状动脉造影和/或介入治疗的研究进行系统检索。使用随机效应模型通过荟萃分析汇总数据。比值比(OR)及其相对95%置信区间(CI)和标准化均数差值用作效应估计量度。主要终点是总体RAO的发生情况。结果:共纳入6项研究和6793例患者。与单纯桡动脉压迫相比,SURC方法总体上(OR 0.29;95%CI,0.13−0.61,p<0.001;需治疗获益人数[NNTB]=38)和住院期间(OR 0.28;95%CI:0.10至0.75;p = 0.01,NNTB = 36)RAO风险较低,成功止血失败风险降低(OR:0.13;95%CI:0.02至0.85;p = 0.03,NNT = 5),上肢疼痛风险降低(OR:0.48;95%CI:0.24至0.95;p = 0.04,NNTB = 124)。止血时间和血肿风险未观察到显著差异。结论:与单纯桡动脉压迫相比,SURC与较低的RAO、成功止血失败及上肢疼痛报告风险相关,在安全结局方面无任何权衡。随着专用双压迫装置的进一步发展,所提出的技术应摆脱使用限制。